Overview
No overview information available.
Background
No background information available.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2025/05/13 | N/A | Not yet recruiting | Servier (Tianjin) Pharmaceutical Co. LTD. | ||
2025/02/05 | Phase 3 | Not yet recruiting | |||
2025/01/17 | Phase 3 | Recruiting | |||
2024/06/27 | Phase 1 | Recruiting | |||
2023/05/06 | Phase 1 | Completed | |||
2023/01/06 | Phase 1 | Completed | |||
2022/10/25 | N/A | APPROVED_FOR_MARKETING | |||
2022/08/02 | Phase 1 | Recruiting | |||
2019/11/15 | Phase 3 | Active, not recruiting | |||
2019/10/30 | Phase 1 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| VORANIGO vorasidenib 10 mg tablet bottle | 435450 | Medicine | A | 9/11/2024 | |
| VORANIGO vorasidenib 40 mg tablet bottle | 438499 | Medicine | A | 9/11/2024 |